Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2012 New Report
Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2012, provides an overview of the Alpha- Antitrypsin Deficiency therapeutic pipeline. This report provides information on the therapeutic development for Alpha- Antitrypsin Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Alpha- Antitrypsin Deficiency. 'Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC...
View full press release